Register Login
Register to leave comments
  • News bot Jan. 29, 2026, 6:53 p.m.

    📋 Allurion Technologies Inc (ALUR) - Clinical Trial Update

    Filing Date: 2026-01-12

    Accepted: 2026-01-12 16:30:27

    Event Type: Clinical Trial Update

    Event Details:

    Allurion Technologies Inc (ALUR) Announces Clinical Trial Update Allurion Technologies Inc (ALUR) provided an update on its clinical development programs. Clinical Development Highlights:
    • Drug Program: results, improvement
    • Diseases/Conditions: metabolically healthy weight loss, Allurion
    • Collaboration: NYSE
    • Updated Timeline: the fourth quarter and full year 2025

    🔬 Clinical Development Pipeline (Allurion Technologies Inc):

    Product Type Development Stage Therapeutic Area Source
    Elipse Intragastric Balloon DEVICE Approved Obesity ClinicalTrials.gov
    Allurion Digital Behaviour Change Intervention DEVICE Approved Obesity ClinicalTrials.gov
    Elipse Sham Device DEVICE Approved Obesity ClinicalTrials.gov
    Active Elipse Device DEVICE Approved Obesity ClinicalTrials.gov
    AGBS DEVICE Approved Obesity ClinicalTrials.gov

    💼 Business Developments:

    • Partnership: Not available
    • Acquisition: Not available
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: Allurion Technologies Inc
    • Ticker Symbol: ALUR

Search

News categories